[Form 4] ARAMARK Insider Trading Activity

Rhea-AI Filing Summary

Aramark (ARMK) director Kenneth M. Keverian received dividend-equivalent rights tied to deferred stock units on 08/20/2025. The filing reports an acquisition (code A) of 62.2 dividend-equivalent units at a reported price of $0, and shows 23,792.883 shares beneficially owned following the transaction. The dividend-equivalent rights vest on the same schedule as the underlying deferred stock units. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/21/2025.

Insights

Securities Analyst

TL;DR: Director received dividend-equivalent rights increasing beneficial holdings marginally; no cash consideration reported.

The Form 4 discloses a non-derivative acquisition of 62.2 dividend-equivalent units tied to deferred stock awards, recorded as a $0 transaction, which commonly reflects accruals rather than open-market purchases. Post-transaction beneficial ownership is listed as 23,792.883 shares, reported as direct ownership. This is a routine compensation-related adjustment rather than an opportunistic market trade; it does not indicate a change in control or a material shift in ownership stake.

Corporate Governance Expert

TL;DR: Disclosure shows routine vesting-related accruals; impact on investor governance metrics is negligible.

The filing specifies dividend-equivalent rights that vest on the schedules of underlying deferred stock units, suggesting this is part of standard director compensation practices. The transaction code and $0 price are consistent with issuance or accrual rather than a buy or sale. There is no indication of any amendment or corrective filing, and the report was executed by an attorney-in-fact, which aligns with typical procedural handling for insider forms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KEVERIAN KENNETH M

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		62.2(1)	A	$0	23,792.883	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kenneth M. Keverian report on the Form 4 for ARMK?

He reported an acquisition of 62.2 dividend-equivalent units tied to deferred stock units on 08/20/2025, with 23,792.883 shares beneficially owned after the transaction.

Was there any cash paid for the reported transaction on the Form 4?

No. The transaction is reported with a $0 price, consistent with dividend-equivalent accruals rather than a market purchase.

What is the nature of the acquired securities in this Form 4?

The filing describes dividend equivalent rights that accrued on deferred stock units; these rights vest on the same schedule as the underlying awards.

When was the Form 4 signed and filed?

The signature block shows execution by an attorney-in-fact on 08/21/2025, and the reported transaction date is 08/20/2025.